SP364THE COST-UTILITY OF TREATING ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR OR EPOETIN VERSUS ROUTINE BLOOD TRANSFUSIONS AMONG CHRONIC HEMODIALYSIS PATIENTS

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients

International Journal of Nephrology and Renovascular Disease ◽

10.2147/ijnrd.s96027 ◽

2016 ◽

pp. 35 ◽

Cited By ~ 5

Author(s):

Omar Maoujoud ◽

Samir Ahid ◽

Yahia Cherrah

Keyword(s):

Hemodialysis Patients ◽

Cost Utility ◽

Chronic Hemodialysis ◽

Erythropoietin Receptor ◽

Blood Transfusions ◽

Routine Blood ◽

Receptor Activator ◽

Continuous Erythropoietin Receptor Activator ◽

The Cost

Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator

10.1111/1744-9987.13537 ◽

2020 ◽

Vol 24 (5) ◽

pp. 602-606

Author(s):

Shoichiro Daimon

Keyword(s):

Darbepoetin Alfa ◽

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽

Monthly continuous erythropoietin receptor activator treatment maintains stable hemoglobin levels in routine clinical management of hemodialysis patients

Hemodialysis International ◽

10.1111/j.1542-4758.2011.00608.x ◽

2011 ◽

Vol 16 (1) ◽

pp. 11-19 ◽

Cited By ~ 9

Author(s):

Thomas Weinreich ◽

Frank Leistikow ◽

Hagen-Georg Hartmann ◽

Günter Vollgraf ◽

Frank Dellanna ◽

...

Keyword(s):

Clinical Management ◽

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽

Hemoglobin Maintenance and Dosing Strategies Using Intravenous Continuous Erythropoietin Receptor Activator in Japanese Hemodialysis Patients

10.1111/1744-9987.12013 ◽

2013 ◽

pp. n/a-n/a ◽

Cited By ~ 1

Author(s):

Takayuki Hirai ◽

Yoshiko Nishizawa ◽

Hiroshi Nakazono ◽

Mariko Asai ◽

Hideki Yamashita ◽

...

Keyword(s):

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽

Dosing Strategies ◽

Changes in Hepcidin and Reticulocyte Hemoglobin Equivalent Levels in Response to Continuous Erythropoietin Receptor Activator Administration in Hemodialysis Patients: A Randomized Study

10.1111/1744-9987.12161 ◽

2014 ◽

Vol 18 (5) ◽

pp. 421-426 ◽

Cited By ~ 19

Author(s):

Midori Kakimoto-Shino ◽

Yoshiyuki Toya ◽

Tadashi Kuji ◽

Tetsuya Fujikawa ◽

Satoshi Umemura

Keyword(s):

Randomized Study ◽

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽

Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients

Journal of Pharmacological Sciences ◽

10.1016/j.jphs.2021.05.010 ◽

2021 ◽

Author(s):

Yuki Kawai ◽

Yoshiyuki Toya ◽

Hiromichi Wakui ◽

Tetsuya Fujikawa ◽

Eiko Ueda ◽

...

Keyword(s):

Effective Treatment ◽

Iron Supplementation ◽

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Treatment Interval ◽

Receptor Activator ◽

Monthly Continuous Erythropoietin Receptor Activator Versus Weekly Epoetin-Beta, Similar Hemoglobinization but Different Anisocytosis Degree in Hemodialysis Patients: A Randomized Controlled Trial

Journal of Hematology ◽

10.14740/jh862 ◽

2021 ◽

Vol 10 (6) ◽

pp. 255-265

Author(s):

Miguel G. Uriol-Rivera ◽

Aina Obrador-Mulet ◽

Sonia Jimenez-Mendoza ◽

Antonio Corral-Baez ◽

Leonor Perianez-Parraga ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Randomized Controlled ◽

Epoetin Beta ◽

Receptor Activator ◽

Influence of continuous erythropoietin receptor activator (CERA) administration intervals on erythropoietic effect in hemodialysis patients

Renal Replacement Therapy ◽

10.1186/s41100-016-0071-x ◽

2016 ◽

Vol 2 (1) ◽

Cited By ~ 1

Author(s):

Shoichiro Daimon ◽

Hiromi Nuka ◽

Kinya Kitada ◽

Yasunori Suzuki ◽

Fae Kim ◽

...

Keyword(s):

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽

Long-term effect of CERA (continuous erythropoietin receptor activator) administered once every 2 weeks in hemodialysis patients with anemia

Nihon Toseki Igakkai Zasshi ◽

10.4009/jsdt.46.999 ◽

2013 ◽

Vol 46 (10) ◽

pp. 999-1006

Author(s):

Teruhiko Maeba ◽

Ryo Yoshizawa ◽

Shigeru Owada

Keyword(s):

Hemodialysis Patients ◽

Term Effect ◽

Erythropoietin Receptor ◽

Long Term Effect ◽

Receptor Activator ◽

Comparison of the Effect of the Same Dose of a 4-Weekly Continuous Erythropoietin Receptor Activator Administered Once Every 2 or 4 Weeks in Hemodialysis Patients

10.1111/1744-9987.12200 ◽

2014 ◽

Vol 18 (5) ◽

pp. 518-520 ◽

Cited By ~ 1

Author(s):

Shoichiro Daimon

Keyword(s):

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽